Collplant Biotechnologies Ltd
CLGN0.800USD
+0.050+6.65%
終値 02/06, 16:00（ET）15分遅れの株価
10.22M時価総額
損失額直近12ヶ月PER
詳細情報 Collplant Biotechnologies Ltd 企業名
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Collplant Biotechnologies Ltdの企業情報
企業コードCLGN
会社名Collplant Biotechnologies Ltd
上場日Sep 01, 1993
最高経営責任者「CEO」Rotem (Eran)
従業員数57
証券種類Ordinary Share
決算期末Sep 01
本社所在地4 Oppenheimer Street
都市REHOVOT
証券取引所NASDAQ OMX - NASDAQ BASIC
国Israel
郵便番号7670104
電話番号972732325600
ウェブサイトhttps://www.collplant.com
企業コードCLGN
上場日Sep 01, 1993
最高経営責任者「CEO」Rotem (Eran)
Collplant Biotechnologies Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
Dr. Elan Penn, Ph.D.
Dr. Elan Penn, Ph.D.
Independent Director
Independent Director
--
--
Dr. Roger J. Pomerantz, M.D.
Dr. Roger J. Pomerantz, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
31.14K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
2.00K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q2
FY2024
FY2024Q2
FY2023
FY2023Q2
FY2022
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Revenues from the sales of goods
179.00K
0.00%
地域別USD
会社名
収益
比率
Northern America
159.00K
88.83%
Europe
20.00K
11.17%
事業別
地域別
事業別USD
会社名
収益
比率
Revenues from the sales of goods
179.00K
0.00%
株主
更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
Sagy (Ami)
12.81%
Loewenbaum (George Walter II)
9.83%
St. Denis J. Villere & Company, LLC
4.75%
Pinnacle Associates Ltd.
4.36%
Loewenbaum (Lilian Shaw)
3.18%
他の
65.06%
株主統計
株主統計
比率
Sagy (Ami)
12.81%
Loewenbaum (George Walter II)
9.83%
St. Denis J. Villere & Company, LLC
4.75%
Pinnacle Associates Ltd.
4.36%
Loewenbaum (Lilian Shaw)
3.18%
他の
65.06%
種類
株主統計
比率
Individual Investor
29.81%
Investment Advisor
7.56%
Investment Advisor/Hedge Fund
5.38%
Hedge Fund
1.74%
Research Firm
0.14%
Family Office
0.13%
他の
55.25%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
34
1.82M
18.05%
--
2025Q3
36
1.82M
18.09%
-351.44K
2025Q2
36
2.17M
13.51%
+569.42K
2025Q1
36
2.09M
19.82%
-180.41K
2024Q4
38
2.54M
24.36%
-57.22K
2024Q3
40
2.59M
23.16%
+143.75K
2024Q2
40
2.45M
24.33%
+72.69K
2024Q1
40
2.38M
24.25%
-401.71K
2023Q4
45
2.39M
26.23%
-101.34K
2023Q3
46
2.49M
28.02%
-60.71K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Sagy (Ami)
1.64M
12.81%
-306.10K
-15.75%
Nov 19, 2025
Loewenbaum (George Walter II)
1.26M
9.83%
--
--
Nov 06, 2025
St. Denis J. Villere & Company, LLC
588.72K
4.61%
+41.85K
+7.65%
Sep 30, 2025
Pinnacle Associates Ltd.
507.19K
3.97%
--
--
Sep 30, 2025
Loewenbaum (Lilian Shaw)
406.29K
3.18%
-245.19K
-37.64%
Nov 06, 2025
Evans (Hugh M)
377.43K
2.95%
-1.00
-0.00%
Mar 15, 2025
Roumell Asset Management, L.L.C.
276.43K
2.16%
-38.86K
-12.32%
Jun 30, 2024
AMH Equity, Ltd.
200.00K
1.57%
+39.15K
+24.34%
Sep 30, 2025
Brown Advisory
118.73K
0.93%
+7.55K
+6.79%
Sep 30, 2025
Benjamin F. Edwards & Company, Inc.
39.76K
0.31%
-10.69K
-21.19%
Jun 30, 2024
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
